Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nanomedicine is Scopus-indexed (Q1, CiteScore 6.5), WoS SCIE. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1743-5889Verify ISSN ↗1748-6963Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Development | 40 / 314 | 87th | Q1 |
| Medicine (miscellaneous) | 84 / 466 | 82nd | Q1 |
| Materials Science (all) | 141 / 475 | 70th | Q2 |
| Biomedical Engineering | 116 / 342 | 66th | Q2 |
| Bioengineering | 73 / 168 | 56th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q1, CiteScore 6.5.
Nanomedicine is Q1 in Development (rank 40 of 314), Q1 in Medicine (miscellaneous) (rank 84 of 466) and Q2 in Materials Science (all) (rank 141 of 475), by CiteScore 2025. It is ranked in 5 subject areas in all.
Nanomedicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.5, which places it in quartile Q1 at the 87th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.681, quartile Q1, with an H-index of 148.
Nanomedicine is published by Taylor and Francis Ltd. Its print ISSN is 1743-5889 and its online ISSN is 1748-6963.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Nanomedicine has an h-index of 160 and a 2-year mean of 4.85 citations per paper (OpenAlex). Its Scopus CiteScore is 6.5, quartile Q1. On 2-year citations it ranks #22 of 299 Scopus journals in Development.
Nanomedicine published 240 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2026), authors are most often from China (27.3%), India (14.2%) and United States (13.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 15 retracted papers are recorded (3.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.